That's the default response from the junk science
Post# of 123460
(Total Views: 205)
Posted On: 03/18/2022 3:28:18 PM
That's the default response from the junk science conspiracy theory mongers. ALWAYS something behind the curtain, down the road.
Do you ever pay attention to the TV pharm ads? They always rattle off contraindications and warnings, including the chance of dying.
It the same for vaxxes; risk VS benefits.
Bottom lime, if you don't present with a liver problem then you're very unlikely to induce one with a Covid Vax. Think they didn't test for it?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372667/
Pfizer/BioNTech BNT162b2 mRNA trial included only 0.6% (217/37,706) patients with liver disease. Among patients with liver disease, 214 were with mild liver disease and only three with moderate to severe liver disease.
This patient has underlying fatty liver disease. It is unclear if that was a likely risk factor for hepatotoxicity in this case [5]. Although only a small number were included in trials for Pfizer/BioNTech BNT162b2 mRNA, Moderna mRNA-1273, and the AstraZeneca/University of Oxford ChAdOx1-nCoV-19 chimpanzee adenovirus vector vaccine, both the American Association for Study of Liver Diseases and European Association for the Study of Liver recommend vaccination against SARS-COV-2 with these highly effective and safe vaccines, given a greater risk of health consequences from SARS-COV-2 infection in these patients [29,30].
Hepatotoxicity can occur with vaccines, even though it is more common with prescription and nonprescription drugs. So, the clinician should be watchful in patients showing clinical signs and symptoms after a vaccine.
Do you ever pay attention to the TV pharm ads? They always rattle off contraindications and warnings, including the chance of dying.
It the same for vaxxes; risk VS benefits.
Bottom lime, if you don't present with a liver problem then you're very unlikely to induce one with a Covid Vax. Think they didn't test for it?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372667/
Pfizer/BioNTech BNT162b2 mRNA trial included only 0.6% (217/37,706) patients with liver disease. Among patients with liver disease, 214 were with mild liver disease and only three with moderate to severe liver disease.
This patient has underlying fatty liver disease. It is unclear if that was a likely risk factor for hepatotoxicity in this case [5]. Although only a small number were included in trials for Pfizer/BioNTech BNT162b2 mRNA, Moderna mRNA-1273, and the AstraZeneca/University of Oxford ChAdOx1-nCoV-19 chimpanzee adenovirus vector vaccine, both the American Association for Study of Liver Diseases and European Association for the Study of Liver recommend vaccination against SARS-COV-2 with these highly effective and safe vaccines, given a greater risk of health consequences from SARS-COV-2 infection in these patients [29,30].
Hepatotoxicity can occur with vaccines, even though it is more common with prescription and nonprescription drugs. So, the clinician should be watchful in patients showing clinical signs and symptoms after a vaccine.
(0)
(0)Scroll down for more posts ▼